Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy. (2025). Vascular and Endovascular Review, 8(10s), 203-216. https://verjournal.com/index.php/ver/article/view/812